For years, medical experts have defined obesity primarily based on body mass index, which measures stored fat by calculating height and weight, to determine a person’s health risks. Major public ...
The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...
Research identifies key factors affecting semaglutide initiation among obese individuals without diabetes, revealing ...
A parasitic worm infection, also known as a helminth infection, occurs when parasitic worms, or helminths, infect the body.
According to the Centers for Disease Control and Prevention, more than two in five American adults have obesity, a common and ...
TUESDAY, Jan. 21, 2025 (HealthDay News) -- Black people with obesity are less likely to get weight-loss surgery than others.
A study found that the triglyceride-glucose (TyG) index, combined with obesity measures, significantly correlates with ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
Obesity medications promise transformative care, but financial and systemic barriers limit access for those most in need.
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...
A study by Mass General Brigham investigators shows persistent racial disparities and growing sex disparities between ...
A global commission of experts has called for a radical shift in how obesity is diagnosed, with less reliance on body mass index (BMI) to define disease. The commission, published in Lancet Diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback